MAPA PHARMA SL
Company details
- Active NIF/CIF: B67243923
-
-
-
-
Address: RB ONCE DE SEPTIEMBRE NUM51 P4 PTA1 (BARCELONA)
-
-
Featured products:

More information on MAPA PHARMA SL
-
11/02/2025 | BORME act no.: 67061 | Register: BARCELONARevocaciones
-
11/02/2025 | BORME act no.: 67061 | Register: BARCELONANombramientos
-
26/12/2019 | BORME act no.: 537018 | Register: BARCELONARevocaciones
-
26/12/2019 | BORME act no.: 537018 | Register: BARCELONANombramientos
-
16/07/2018 | BORME act no.: 293291 | Register: BARCELONAConstitución
-
16/07/2018 | BORME act no.: 293291 | Register: BARCELONANombramientos
-
16/07/2018 | BORME act no.: 293291 | Register: BARCELONAOtros conceptos
Other information
The CIF assigned to MAPA PHARMA SL is B67243923, and its business status is active. The company is engaged in an economic activity classified within the CNAE 4618 - Intermediarios del comercio especializados en la venta de otros productos específicos. In addition, its SIC identification - also defines it.
MAPA PHARMA SL employs a team of Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona, and has 4 executive positions. Its most recent announcement in the Borme was published on 11/02/2025, while its last deposit of ordinary annual accounts is for the 2023 fiscal year.
To access the contact information of MAPA PHARMA SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about MAPA PHARMA SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about MAPA PHARMA SL is extracted from official sources and is updated daily.
Do you want to know more about MAPA PHARMA SL??
Find out more about this company by consulting these reports: